Sajjad Ullah Mphil: The Impact of Pharmacist-Led Anticoagulation Care in VTE
Sajjad Ullah Mphil, Pharmacist at Shaukat Khanum Memorial Cancer Hospital and Research Centre, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am happy to share that our article has been published, offering valuable insights into ‘Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence.’
Cancer patients are at a significantly higher risk of both thrombosis and bleeding, making anticoagulation management particularly complex.
This study was conducted to explore the impact of pharmacist-led anticoagulation care, focusing on its role in optimizing therapy, minimizing bleeding risks, and reducing the recurrence of venous thromboembolism (VTE).
Our findings add to the growing evidence supporting the clinical value of pharmacist involvement in multidisciplinary cancer care.
This landmark reflects dedication, enthusiasm, and strong leadership support.
I would like to express my sincere gratitude to Sir Omar Akhlaq Bhutta and my supervisor, Dr. Inayat Ur Rehman, for their constant guidance and unwavering support throughout this journey.
I am also deeply thankful to my co-author Dr. Javeria Khalid for her persistent support during challenging times.
Special appreciation to Dr. Yasir Shah and Prof. Long Ming for their continuous encouragement, patience, and motivation toward progress.
This will contribute to improving patient care and advancing the role of pharmacists in clinical practice.”
Title: Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence
Authors: Sajjad Ullah, Inayat Ur Rehman, Javeria Khalid, Yasar Shah, Omar Akhlaq Bhutta, Long Chiau Ming
Read the Full Article on Journal of Oncology Pharmacy Practice
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation
-
Aug 21, 2026, 09:07Sujal Lohana: Building a Better Blood Donor–Seeker App
-
Aug 21, 2026, 08:55Robert Sidonio: Connecting Experts in Bleeding and Clotting Disorders